ArticleGut microbes2026
GUTchetp: integrated prediction of gut microbial biotransformation profiles using ensemble monolingual and multilingual neural machine translation and enzyme class consistency-reaction similarity.
Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The analysis of the metabolic fate of chemical compounds in the human gut remains a fundamental challenge, as comprehensive experimental characterization across the vast chemical space is infeasible. Moreover, despite progress in computational biology, a comprehensive tool for predicting microbe-dependent metabolism of diverse chemicals is still lacking. To address these challenges, we introduce the GUTchetp framework, which comprises two components: one predicts gut biotransformation products and was tested on a benchmark of six compound categories, whereas the other identifies the associated microbial enzymes and species and was evaluated on a benchmark of 95 metabolism events. The first component employs an ensemble of monolingual and multilingual neural machine translation models, integrating transfer learning, mixed fine-tuning, multiple molecular representations, and adaptive data augmentation. The ensemble model outperformed previous approaches, achieving a Top-20 BLEU score and MaxFrag accuracy of 66.59% and 67.19%, respectively. The second component applies a re-ranking rule that combines the prediction consistency between two Enzyme Commission (EC) number classifiers with chemical reaction similarity, increasing accuracy by 34.38 percentage points over existing tools on the hidden dataset. Both components showed statistically significant improvements compared with existing tools, enabling the accurate prediction of 68.42% of known gut microbial biotransformation profiles, which is highly promising for anticipating gut microbial biotransformation outcomes. GUTchetp will thus pave the way for predicting the capacity of personalized gut microbiomes to metabolize intentional xenobiotics, such as pharmaceuticals and nutrients, and unintentional ones, such as environmental chemicals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.